| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.007 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |